RANI
NASDAQ · Pharmaceuticals
Rani Therapeutics Holdings-A
$0.57
+0.02 (+3.06%)
Open$0.57
Previous Close$0.56
Day High$0.58
Day Low$0.56
52W High$2.63
52W Low$0.57
Volume—
Avg Volume462.6K
Market Cap82.24M
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+6,385.7% upside
Current
$0.57
$0.57
Target
$37.15
$37.15
$30.65
$37.15 avg
$44.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.34M | 3.95M | 51.04M |
| Net Income | -60,605,258 | -64,657,103 | 8.38M |
| Profit Margin | -1,817.1% | -1,726.2% | 16.4% |
| EBITDA | -77,569,868 | -87,353,454 | 12.88M |
| Free Cash Flow | — | — | 6.14M |
| Rev Growth | -15.6% | -15.6% | +13.5% |
| Debt/Equity | — | — | 0.99 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |